Indianapolis, IN, United States of America

David A Williams

This inventor holds 10 USPTO granted patents. Top assignees: Indiana University, Advanced Research & Technology Institute, Genetics Institute, Inc.. Active years: 1995-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Williams. Retrieved from https://idiyas.com/inventor/david-a-williams-xlfswpkz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 122(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Unleashing the Power of Retroviruses: The Innovations of David A Williams

Introduction:

David A Williams, a prolific inventor based in Indianapolis, IN, has made significant strides in the field of gene therapy with a total of 10 patents to his name. His innovative approaches have revolutionized the efficiency of transduction of hematopoietic and other cells using retroviruses.

Latest Patents:

Among his latest patents, one notable invention is the "Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains." This method enhances retroviral-mediated gene transfer into cells, particularly hematopoietic cells, by infecting the cells in the presence of fibronectin or fibronectin fragments. This breakthrough opens new possibilities in somatic gene therapy and gene transfer technologies.

Career Highlights:

David A Williams has contributed his inventive genius to esteemed institutions such as the Advanced Research & Technology Institute and the Indiana University Foundation. His dedication to advancing gene therapy technologies has propelled these organizations to the forefront of medical innovation.

Collaborations:

In his quest for innovation, David A Williams has collaborated with visionaries in the field, including Vikram P Patel and Mark R Kelley. Together, they have pushed the boundaries of retroviral-mediated DNA transfer, paving the way for groundbreaking advancements in gene therapy.

Conclusion:

In conclusion, David A Williams stands as a beacon of innovation in the realm of gene therapy. His patents and collaborations have reshaped the landscape of retroviral-mediated gene transfer, offering hope for improved treatments and therapies in the realm of genetic medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…